We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

VOYA:NYSEVoya Financial, Inc. Analysis

Data as of 2026-07-30 - not real-time

$100.27

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

Voya Financial is trading above its 20‑day and 50‑day simple moving averages, while still below the 200‑day SMA, indicating a short‑term bullish bias within a longer‑term uptrend. RSI sits near 65, suggesting momentum remains strong but is not yet in overbought territory. The MACD shows a bearish histogram, hinting at a possible near‑term pullback, yet the price remains well above the identified support around $93. Volume has been decreasing, which could limit upside momentum but also reflects a more stable trading environment. The DCF‑derived fair value of roughly $196 is nearly double the current market price, implying a substantial undervaluation with an upside potential of about 4% according to the model. Dividend yield close to 2% and a modest payout ratio reinforce cash‑flow comfort.
Analyst consensus is a “buy” with a median target near $106, and the forward PE of under 9x positions Voya as a value‑oriented play despite modest revenue growth. The company’s low beta (~0.8) and a 30‑day volatility around 20% suggest limited price swings relative to the market. Recent news of a declared common‑stock dividend underscores confidence in cash generation. Overall, the blend of technical support, attractive valuation gaps, and sustainable dividend income makes Voya a compelling candidate for investors seeking upside with limited downside.

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 7/10

Key Factors

  • Price above 20‑day SMA indicating short‑term bullish momentum
  • Support level near $93 providing downside cushion
  • Attractive dividend yield with low payout ratio

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Undervaluation relative to DCF fair value
  • Forward PE under 9x suggesting strong earnings upside
  • Stable cash flow and sustainable dividend

Long Term

> 3 years
Positive
Model confidence: 9/10

Key Factors

  • Long‑term uptrend above 200‑day SMA
  • Low beta and moderate volatility limiting systematic risk
  • Consistent earnings growth and strong balance‑sheet metrics

Key Metrics & Analysis

Financial Health

Revenue Growth3.10%
Profit Margin8.24%
P/E Ratio15.1
ROE11.89%
ROA0.42%
Debt/Equity73.44
P/B Ratio2.0
Op. Cash Flow$1.4B
Free Cash Flow$1.5B
Industry P/E18.1

Technical Analysis

TrendBullish
RSI65.5
Support$93.37
Resistance$103.85
MA 20$98.11
MA 50$91.43
MA 200$77.96
MACDBearish
VolumeDecreasing
Fear & Greed Index90.91

Valuation

Fair Value$196.47
Target Price$104.25
Upside/Downside3.97%
GradeUndervalued
TypeValue
Dividend Yield1.88%

Risk Assessment

Beta0.79
Volatility20.02%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.